Misplaced Pages

MDMAR

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
(Redirected from 3',4'-Methylenedioxy-4-methylaminorex) Chemical compound Pharmaceutical compound
3',4'-Methylenedioxy-4-methylaminorex
Clinical data
Other names3',4'-Methylenedioxy-4-methylaminorex
Identifiers
IUPAC name
  • 5-(1,3-benzodioxol-5-yl)-4-methyl-4,5-dihydro-1,3-oxazol-2-amine
CAS Number
PubChem CID
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H12N2O3
Molar mass220.228 g·mol
3D model (JSmol)
SMILES
  • CC1C(OC(=N1)N)C2=CC3=C(C=C2)OCO3
InChI
  • InChI=1S/C11H12N2O3/c1-6-10(16-11(12)13-6)7-2-3-8-9(4-7)15-5-14-8/h2-4,6,10H,5H2,1H3,(H2,12,13)
  • Key:JFKNBDXNCLMRPL-UHFFFAOYSA-N

3',4'-Methylenedioxy-4-methylaminorex (MDMAR) is a recreational designer drug from the substituted aminorex family, with monoamine-releasing effects.

See also

References

  1. McLaughlin G, Morris N, Kavanagh PV, Power JD, Twamley B, O'Brien J, et al. (July 2015). "Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3',4'-methylenedioxy-4-methylaminorex (MDMAR)". Drug Testing and Analysis. 7 (7): 555–64. doi:10.1002/dta.1732. PMC 5331736. PMID 25331619.
  2. Zawilska JB, Andrzejczak D (December 2015). "Next generation of novel psychoactive substances on the horizon - A complex problem to face". Drug and Alcohol Dependence. 157: 1–17. doi:10.1016/j.drugalcdep.2015.09.030. PMID 26482089.
  3. Maier J, Mayer FP, Brandt SD, Sitte HH (October 2018). "DARK Classics in Chemical Neuroscience: Aminorex Analogues". ACS Chemical Neuroscience. 9 (10): 2484–2502. doi:10.1021/acschemneuro.8b00415. PMC 6287711. PMID 30269490.
Stub icon

This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.

Categories: